418 - ADVANCES IN UNDERSTANDING ATHEROSCLEROSIS TREATMENT OPTIONS

Saturday, October 29, 2022

12:00 PM – 12:20 PM EDT

Location: Canada Hall 2 West

Sponsored By

Target Audience: General: All cardiovascular (clinical and research) health professionals, Community cardiologists, Clinical cardiologists

Chair(s)

Subodh Verma, MD PhD

Cardiac Surgeon
St Michael's Hospital, University of Toronto, ON
Toronto, United States

At the conclusion of this session, participants will be able to:

differentiate between different formulations of omega-3 fatty acids used in cardiovascular outcome trials;
review mechanistic studies and basic research that examine the role of omega-3 fatty acids in reducing CV events; and
discuss clinical application of omega-3 fatty acids for high-risk patients.

Atherosclerosis experts discuss advances in atherosclerosis therapies. What could this mean for patients with a high atherosclerotic disease burden?